Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Orion Corporation: Managers' transactions - Timo Lappalainen

Orion Oyj
Posted on: 02 Mar 18

ORION CORPORATION           MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET            

Orion Corporation: Managers' transactions - Timo Lappalainen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Person subject to the notification requirement
Name: Lappalainen, Timo 
Position: Chief Executive Officer
Initial Notification  
Reference number: 74370029VAHCXDR7B745_20180301120919_6
Name: Orion Oyj
LEI: 74370029VAHCXDR7B745
Transaction details
Transaction date: 2018-03-01
Nature of the transaction: Receipt of a Share-Based Incentive or Remuneration
Instrument: Share
ISIN: FI0009014377
Volume: 13457
Unit price: 0.00000 Euro
Aggregated transactions
Volume: 13457
Volume weighted average price: 0.00000 Euro

Orion Corporation

Timo LappalainenOlli Huotari
President and CEO   SVP, Corporate Functions


Orion Corporation
Orionintie 1A, FI-02200 Espoo

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Orion Oyj via GlobeNewswire

Last updated on: 03/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.